Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2017

Planlagt Fastgjort Låst Flyttet Genmab
4.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #2850

    ja, og så får vi TV i andre solide end livmoderhals på enten asco eller esmo.

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #2851

      Kunne være godt hvis fokus kunne rettes andre steder hen også, - så ja lad os håbe der kommer lidt pip derfra 😉

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #2852

        Du har da ret, men jeg er alligevel meget spændt på om der kommer et abs på Alcyone på tirsdag og om data er gode. Ikke så meget fordi Alcyone i sig selv er så pokkers vigtig, men det vil pege frem mod endnu bedre data i Maia - og det er vigtigt pga det amerikanske marked.

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #2853

          Angående ofa MS så tager det også 3-6 måneder at færdiggøre
          ansøgningen

          1 Reply Last reply
          0
          • nohopeN Offline
            nohopeN Offline
            nohope
            wrote on sidst redigeret af
            #2854

            Så bedste fald er nok ikke salg før 2020 - hvis det overhovedet virker overbevisende i forsøget.

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #2855

              God morgen. 🙂

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #2856

                Flash Nordea "At the SITC conference last week (8-12 November) in National Harbor, Maryland, JnJ showcased its own CD38 preclinical data in lung cancer (NSCLC) as well as early data for its in-house developed anti-PD-1 antibody JNJ-283. We find the data and presentations highly interesting in a Genmab context. First of all, with regards to the CD38 preclinical data in NSCLC, it is, to our knowledge, the first time we see JnJ’s in-house early data for CD38 in solid cancers.

                1 Reply Last reply
                0
                • Legolas23L Offline
                  Legolas23L Offline
                  Legolas23
                  wrote on sidst redigeret af
                  #2857

                  god morgen

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #2858

                    We have previously seen data from JnJ explaining the potential effect of Daratumumab (Darzalex – CD38) on the tumour micro-environment, but that has been from trials in multiple myeloma (depletion of T-regulatory and B-regulatory cells). We have also seen data from Chen et al from MD Anderson Cancer Centre at ASCO-SITC back in February 2017 highlighting very intriguing preclinical results in lung cancer tumours when CD38 was combined with PD-L1.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #2859

                      We have not previously seen in-house preclinical data from JnJ, but that it has now been presented at SITC indicates that JnJ is clearly moving strongly ahead with this hypothesis." og god morgen.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #2860

                        http://jjd_sitc.scientificpresentations.org/Kinder_JJD62532.pdf

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #2861

                          Lidt at studere i dag 🙂

                          1 Reply Last reply
                          0
                          • H Offline
                            H Offline
                            henrik48
                            wrote on sidst redigeret af
                            #2862

                            God nogen og mange tak for gode nyheder

                            1 Reply Last reply
                            0
                            • H Offline
                              H Offline
                              henrik48
                              wrote on sidst redigeret af
                              #2863

                              Morgen

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #2864

                                Tak for fine morgenskriv JKY og Solsen.

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #2865

                                  God morgen. Det har flere gange været diskuteret om J&J potentiels kunne have interesse i at opkøbe Genmab. Eftersom J&J har extimeret Darzalex salg for 2021 til 7B usd vil jeg mene de allerede har indikeret Genmabs potentiale og derfor vil et bud under 2500kr ikke være interessandt for Genmab og hvis vi antager J&J har været konservative i deres estimat burde der snart ske noget positivt med Genmabs kurs. De 7B usd hænger ikke sammen med nuværende lave kurs. Kan nun undre over der nu er short

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #2866

                                    undre over der er short handel på over 0.5% i Genmab p.t

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      rex_pacis
                                      wrote on sidst redigeret af
                                      #2867

                                      det er dog kun en enkelt og kun 0,51, der blev ikke indberettet flere i fredags som vi ellers spekulerede på

                                      1 Reply Last reply
                                      0
                                      • Legolas23L Offline
                                        Legolas23L Offline
                                        Legolas23
                                        wrote on sidst redigeret af
                                        #2868

                                        Ud over det er rigtig dyrt er den gode nyhed, det kun bliver dyere for dem.

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #2869

                                          Tak JKY og Solsen. Så hvor Chen's opdagelse gik på at dara ville være en fin makker for en PD-L1-hæmmer, så går det her studie på at vise at dara kan godt selv. Både direkte celledræbende og indirekte immunmodulerende.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger